Henry Schein Inc. (HSIC)
NASDAQ: HSIC
· Real-Time Price · USD
71.66
0.33 (0.46%)
At close: May 23, 2025, 3:59 PM
71.65
-0.01%
After-hours: May 23, 2025, 04:06 PM EDT
Henry Schein Revenue Breakdown
| Period Ending | Dec 29, 2018 | Dec 31, 2016 | Dec 26, 2015 | Dec 27, 2014 | Dec 28, 2013 | Dec 29, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|
| Healthcare Distribution Revenue | 12.69B | 11.15B | 10.27B | 10.02B | 9.24B | 8.66B | 8.28B |
| Healthcare Distribution Revenue Growth | +13.88% | +8.52% | +2.48% | +8.46% | +6.75% | +4.55% | n/a |
| Technology Revenue | 509.25M | 425.61M | 358.77M | 348.88M | 320.05M | 283.41M | 250.62M |
| Technology Revenue Growth | +19.65% | +18.63% | +2.84% | +9.01% | +12.93% | +13.08% | n/a |
Revenue by Geography
| Period Ending | Dec 29, 2018 | Dec 31, 2016 | Dec 26, 2015 | Dec 27, 2014 | Dec 28, 2013 | Dec 29, 2012 | Dec 31, 2011 | Dec 25, 2010 |
|---|---|---|---|---|---|---|---|---|
| International Revenue | 4.85B | 4.03B | 3.83B | 4.12B | 3.75B | 3.44B | 2.57B | 2.06B |
| International Revenue Growth | +20.29% | +5.32% | -7.12% | +10.07% | +8.83% | +33.80% | +24.88% | n/a |
| United States Revenue | 8.35B | 7.54B | 6.8B | 6.25B | 5.81B | 5.5B | 5.21B | 4.78B |
| United States Revenue Growth | +10.77% | +10.86% | +8.83% | +7.46% | +5.76% | +5.45% | +9.12% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 26, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 738M | 738M | 724M | 781M | 791M | 807M | 725M | 707M | 717M | 761M | 648M | 680M | 682M | 774.36M | 701.5M | 678.8M | 657.99M | 674.13M | 559.64M | 445.79M | 567.39M | 615.32M | 574.77M | 593.22M | 574.61M | 674.74M | 668.01M | 677.22M | 685.69M | 659.76M | 622.51M | 628.51M | 628.95M | 631.79M | 583.4M | 602.26M | 599.05M | 586.18M | 551.59M | 560.43M | 545.17M |
| Selling, General, and Administrative Revenue Growth | 0.00% | +1.93% | -7.30% | -1.26% | -1.98% | +11.31% | +2.55% | -1.39% | -5.78% | +17.44% | -4.71% | -0.29% | -11.93% | +10.39% | +3.34% | +3.16% | -2.39% | +20.46% | +25.54% | -21.43% | -7.79% | +7.06% | -3.11% | +3.24% | -14.84% | +1.01% | -1.36% | -1.24% | +3.93% | +5.99% | -0.96% | -0.07% | -0.45% | +8.30% | -3.13% | +0.53% | +2.20% | +6.27% | -1.58% | +2.80% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |